Once again, US pharma giant Pfizer is having to pay out millions of dollars to the US federal government and states to settle charges of illegal promotion of the company's medicines, with the latest settlements totaling about $98 million1. While a far cry from the $2.3 billion the New York drug maker paid under a 2009 guilty plea for promoting its cyclooxygenase-2-selective nonsteroidal anti-inflammatory drug Bextra (valdecoxib), this is still a tidy sum of cash2.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?